about
SMN is required for sensory-motor circuit function in Drosophila.Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a.A role for BK channels in heart rate regulation in rodentsMechanism of action of lolitrem B, a fungal endophyte derived toxin that inhibits BK large conductance Ca²+-activated K+ channels.The molecular mechanism of "ryegrass staggers," a neurological disorder of K+ channels.The p150(Glued) CAP-Gly domain regulates initiation of retrograde transport at synaptic termini.Glycinergic dysfunction in a subpopulation of dorsal horn interneurons in a rat model of neuropathic pain.Glycine transport inhibitors for the treatment of pain.New approaches to target glycinergic neurotransmission for the treatment of chronic pain.Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief.Miniature neurotransmission regulates Drosophila synaptic structural maturation.Structural determinants of lolitrems for inhibition of BK large conductance Ca2+-activated K+ channels.A comparison of the anti-inflammatory and immuno-stimulatory activities of orf virus and ovine interleukin-10.An SMN-dependent U12 splicing event essential for motor circuit functionRegulation of Fasciclin II and synaptic terminal development by the splicing factor beag.Electrophysiological methods for recording synaptic potentials from the NMJ of Drosophila larvae.A Positive Allosteric Modulator of the Adenosine A1 Receptor Selectively Inhibits Primary Afferent Synaptic Transmission in a Neuropathic Pain Model.A sleep/wake circuit controls isoflurane sensitivity in Drosophila.The light touch of delta opioid receptors.Orf virus immuno-modulation and the host immune response.Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission.Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord.A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic painPathological Mechanisms and Therapeutic Targets for Trigeminal Neuropathic Pain
P50
Q30525692-54634B86-CDFE-4E06-BD54-781D669FF922Q30835612-E8DB8DA8-A221-4024-8ED7-98CD323011F7Q33525523-657DF97D-2298-4945-841E-FCF03B3B7B9DQ34163087-78B9BD0F-6DC7-49A2-80DE-634BB3DC86C2Q34830961-BAB8FA97-F8FA-4989-AE8C-2C77AA30F6BCQ35965342-60064FD5-A899-4147-AD3F-894B6221A052Q37411774-1BC4AC9F-999B-4490-82F4-5A6053E677C9Q38222971-8EDDDEBF-75B8-47CE-B8B0-6A177005C5F9Q39042271-2B8C1A7A-C60C-4E27-B066-C4EC5A2F99FAQ39154920-7566749C-78BD-4721-A7E4-60E43A63ECF9Q39661232-EE48D6D3-BE95-4521-88E9-DD16E5115BE3Q39884968-1983F7FC-4A7A-4144-A5DA-0E28C1475877Q40686669-0BEE7E04-E44D-4066-B073-615388E376A7Q41856470-C829F081-AE6A-4531-A6F6-63E043B3BFC1Q41969892-0BDC09AF-700A-4A33-846B-FB69839A2461Q42016399-33F8F525-4459-4825-B9D4-1DBE6DAD9993Q42701396-7761BF0B-CA6C-4E4B-8B27-0600EBF4BB1BQ43666729-89AC8F3C-39C2-4B26-BF70-69CA21B776FFQ44344085-A0F0EF45-A98D-40EC-B94F-B7A11D5A1356Q45732106-FE47615C-C9B1-4DC7-8DAF-EF8AFDADF935Q47583720-68414CFA-E61A-4117-90DF-AEE9C0E652E7Q52676204-82F40209-08D6-462C-A8B2-BE46A92F3AB4Q91106613-FB223C5B-A5E9-4C88-8030-72A182D5C207Q92826572-9CEED4CF-844B-4684-B706-EA70F1788844
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Wendy L Imlach
@nl
Wendy L Imlach
@sl
Wendy L. Imlach
@en
Wendy L. Imlach
@es
type
label
Wendy L Imlach
@nl
Wendy L Imlach
@sl
Wendy L. Imlach
@en
Wendy L. Imlach
@es
prefLabel
Wendy L Imlach
@nl
Wendy L Imlach
@sl
Wendy L. Imlach
@en
Wendy L. Imlach
@es
P1053
G-7609-2011
P106
P1153
7801680176
P2038
Wendy_Imlach
P21
P31
P3829
P496
0000-0002-7521-9969